Haemonetics Corp. (NYSE: HAE) reported Q1 EPS of $0.38, $0.02 better than the analyst estimate of $0.36. Revenue for the quarter came in at $224.49 million versus the consensus estimate of $215.85 million.

For earnings history and earnings-related data on Haemonetics Corp. (HAE) click here.